INmune Bio, Inc. (INMB)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 11.13 |
| Open | 11.17 |
| Bid | 11.54 x 200 |
| Ask | 11.63 x 200 |
| Day's range | 11.12 - 11.75 |
| 52-week range | 6.50 - 14.74 |
| Volume | |
| Avg. volume | 112,724 |
| Market cap | 228.635M |
| Beta (5Y monthly) | 1.95 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
INmune Bio Independent Director Acquires 80% More Stock
Potential INmune Bio, Inc. ( NASDAQ:INMB ) shareholders may wish to note that the Independent Director, Scott Juda...
- Insider Monkey
INmune Bio, Inc. (NASDAQ:INMB) Q4 2023 Earnings Call Transcript
INmune Bio, Inc. (NASDAQ:INMB) Q4 2023 Earnings Call Transcript March 28, 2024 INmune Bio, Inc. beats earnings expectations. Reported EPS is $-0.47, expectations were $-0.58. INMB isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Ladies and gentlemen, greetings and welcome […]
- Simply Wall St.
INmune Bio Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
INmune Bio ( NASDAQ:INMB ) Full Year 2023 Results Key Financial Results Net loss: US$30.0m (loss widened by 9.9% from...
© 2024 Yahoo. All rights reserved.